Email updates

Keep up to date with the latest news and content from BMC Cancer and BioMed Central.

Open Access Email this article to a friend

Safety and efficacy of everolimus in Chinese patients with metastatic renal cell carcinoma resistant to vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy: an open-label phase 1b study

Jun Guo*, Yiran Huang, Xu Zhang, Fangjian Zhou, Yinghao Sun, Shukui Qin, Zhangqun Ye, Hui Wang, Annette Jappe, Patrick Straub, Nicoletta Pirotta and Sven Gogov

BMC Cancer 2013, 13:136  doi:10.1186/1471-2407-13-136

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.
How can I ensure that I receive BMC Cancer's emails?